Related Experiment Video
Updated: Sep 13, 2025

06:55
Ileectomy-induced Bile Overaccumulation in Mouse Intestine
Published on: August 21, 2017
9.6K
Clay Attenuates Diarrhea Induced by Fat in a Mouse Model.
Shalom Emmanuel1, Nyma Siddiqui1, Ting Du1
1Department of Pharmaceutical Science, College of Pharmacy and Health Sciences, Texas Southern University, 3100 Cleburne Street, Houston, TX 77004, USA.
Metabolites
|July 25, 2025
Summary
A new mouse model for fat-induced diarrhea was developed using glyceryl-trioleate (GTO). Montmorillonite clay (MMT) significantly reduced diarrhea severity by modulating fecal bile acids and colon inflammation.
Area of Science:
- Gastroenterology
- Pharmacology
- Animal Models
Background:
- Fat-induced diarrhea is a common gastrointestinal issue.
- Limited animal models and treatments exist for fat-related diarrhea.
- Developing effective models and therapies is crucial for managing this condition.
Purpose of the Study:
- To establish a mouse model for high-fat-associated diarrhea using glyceryl-trioleate (GTO).
- To evaluate the efficacy of montmorillonite clay (MMT) in treating GTO-induced diarrhea.
- To investigate the underlying mechanisms of MMT's anti-diarrheal effects.
Main Methods:
- A mouse model was established by oral gavage administration of GTO.
- Montmorillonite clay (MMT) was administered to assess its anti-diarrheal properties.
- Fecal analysis, histological examination of intestinal tissues, and fecal bile acid quantification were performed.
Main Results:
- GTO administration at 2000 mg/kg successfully induced a diarrhea model.
- MMT significantly reduced diarrhea incidence and severity in a dose-dependent manner.
- MMT treatment modulated fecal bile acid levels and reduced colon inflammation.
Conclusions:
- GTO is effective in creating a mouse model for fat-induced diarrhea.
- Montmorillonite clay demonstrates significant potential in alleviating fat-induced diarrhea.
- MMT's therapeutic effect is linked to the modulation of fecal bile acids and reduction of intestinal inflammation.
Related Concept Videos
Drugs Affecting GI Tract Motility: Adsorbents as Antidiarrheal Agents
319
Diarrhea is characterized by the occurrence of frequent, watery bowel movements. Various factors can trigger diarrhea, including viral or bacterial infections, foodborne illnesses, side effects from certain medications, and underlying digestive disorders. If not adequately managed, diarrhea can lead to complications such as dehydration, electrolyte imbalances, and nutrient deficiencies. Severe diarrhea can lead to significant weight loss, malnutrition, and weakened immune function.
Adsorbents...
Adsorbents...
319
Drugs for Treatment of Diarrhea-Predominant IBS
299
Diarrhea-predominant irritable bowel syndrome (IBS-D) is a subtype of IBS characterized primarily by frequent, loose, or watery stools, abdominal pain, and abdominal discomfort. Therapeutic approaches to managing IBS-D include dietary changes, stress management techniques, and pharmaceutical interventions.
Two specific drugs used in the treatment are alosetron (Lotronex) and eluxadoline (Viberzi). Alosetron, a 5-HT3 antagonist, works by slowing the movement of stools in the gut, reducing bowel...
Two specific drugs used in the treatment are alosetron (Lotronex) and eluxadoline (Viberzi). Alosetron, a 5-HT3 antagonist, works by slowing the movement of stools in the gut, reducing bowel...
299

